[HTML][HTML] The blood-brain barrier in aging and neurodegeneration

EG Knox, MR Aburto, G Clarke, JF Cryan… - Molecular …, 2022 - nature.com
The blood-brain barrier (BBB) is vital for maintaining brain homeostasis by enabling an
exquisite control of exchange of compounds between the blood and the brain parenchyma …

New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation

N Zisapel - British journal of pharmacology, 2018 - Wiley Online Library
In mammals, a central circadian clock, located in the suprachiasmatic nuclei (SCN) of the
hypothalamus, tunes the innate circadian physiological rhythms to the ambient 24 h light …

[HTML][HTML] Multimodal deep learning models for early detection of Alzheimer's disease stage

J Venugopalan, L Tong, HR Hassanzadeh… - Scientific reports, 2021 - nature.com
Most current Alzheimer's disease (AD) and mild cognitive disorders (MCI) studies use single
data modality to make predictions such as AD stages. The fusion of multiple data modalities …

Trusted multi-view classification with dynamic evidential fusion

Z Han, C Zhang, H Fu, JT Zhou - IEEE transactions on pattern …, 2022 - ieeexplore.ieee.org
Existing multi-view classification algorithms focus on promoting accuracy by exploiting
different views, typically integrating them into common representations for follow-up tasks …

Preparation of near-infrared AIEgen-active fluorescent probes for mapping amyloid-β plaques in brain tissues and living mice

C Yan, J Dai, Y Yao, W Fu, H Tian, WH Zhu, Z Guo - Nature protocols, 2023 - nature.com
Fibrillar aggregates of the amyloid-β protein (Aβ) are the main component of the senile
plaques found in brains of patients with Alzheimer's disease (AD). Development of probes …

[HTML][HTML] Brain MRI analysis for Alzheimer's disease diagnosis using an ensemble system of deep convolutional neural networks

J Islam, Y Zhang - Brain informatics, 2018 - Springer
Alzheimer's disease is an incurable, progressive neurological brain disorder. Earlier
detection of Alzheimer's disease can help with proper treatment and prevent brain tissue …

A review on neuroimaging-based classification studies and associated feature extraction methods for Alzheimer's disease and its prodromal stages

S Rathore, M Habes, MA Iftikhar, A Shacklett… - NeuroImage, 2017 - Elsevier
Neuroimaging has made it possible to measure pathological brain changes associated with
Alzheimer's disease (AD) in vivo. Over the past decade, these measures have been …

[HTML][HTML] Defining imaging biomarker cut points for brain aging and Alzheimer's disease

CR Jack Jr, HJ Wiste, SD Weigand, TM Therneau… - Alzheimer's & …, 2017 - Elsevier
Introduction Our goal was to develop cut points for amyloid positron emission tomography
(PET), tau PET, flouro-deoxyglucose (FDG) PET, and MRI cortical thickness. Methods We …

Tau and Aβ imaging, CSF measures, and cognition in Alzheimer's disease

MR Brier, B Gordon, K Friedrichsen… - Science translational …, 2016 - science.org
Alzheimer's disease (AD) is characterized by two molecular pathologies: cerebral β-
amyloidosis in the form of β-amyloid (Aβ) plaques and tauopathy in the form of neurofibrillary …

[HTML][HTML] Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer's disease

Y Koronyo, D Biggs, E Barron, DS Boyer, JA Pearlman… - JCI insight, 2017 - ncbi.nlm.nih.gov
BACKGROUND. Noninvasive detection of Alzheimer's disease (AD) with high specificity and
sensitivity can greatly facilitate identification of at-risk populations for earlier, more effective …